0 CHECKOUT

Colorectal Cancer - Pipeline Review, H1 2015

  • ID: 3345019
  • June 2015
  • 1299 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 2cureX ApS
  • Biocon Limited
  • Eddingpharm
  • ImmuneXcite, Inc.
  • Multimmune GmbH
  • Puma Biotechnology, Inc.
  • MORE

Colorectal Cancer - Pipeline Review, H1 2015

Summary

the, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects.

the report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updation following a stringent READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 2cureX ApS
  • Biocon Limited
  • Eddingpharm
  • ImmuneXcite, Inc.
  • Multimmune GmbH
  • Puma Biotechnology, Inc.
  • MORE

Introduction
Colorectal Cancer Overview
Therapeutics Development
Colorectal Cancer – Therapeutics under Development by Companies
Colorectal Cancer – Therapeutics under Investigation by Universities/Institutes
Colorectal Cancer – Pipeline Products Glance
Colorectal Cancer – Products under Development by Companies
Colorectal Cancer – Products under Investigation by Universities/Institutes
Colorectal Cancer – Companies Involved in Therapeutics Development
Colorectal Cancer – Therapeutics Assessment
Drug Profiles
Colorectal Cancer – Recent Pipeline Updates
Colorectal Cancer – Dormant Projects
Colorectal Cancer – Discontinued Products
Colorectal Cancer – Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Colorectal Cancer, H1 2015
Number of Products under Development for Colorectal Cancer – Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Development by Companies, H1 2015 (Contd..7)
Number of Products under Development by Companies, H1 2015 (Contd..8)
Number of Products under Development by Companies, H1 2015 (Contd..9)
Number of Products under Development by Companies, H1 2015 (Contd..10)
Number of Products under Development by Companies, H1 2015 (Contd..11)
Number of Products under Development by Companies, H1 2015 (Contd..12)
Number of Products under Development by Companies, H1 2015 (Contd..13)
Number of Products under Development by Companies, H1 2015 (Contd..14)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Development by Companies, H1 2015 (Contd..11)
Products under Development by Companies, H1 2015 (Contd..12)
Products under Development by Companies, H1 2015 (Contd..13)
Products under Development by Companies, H1 2015 (Contd..14)
Products under Development by Companies, H1 2015 (Contd..15)
Products under Development by Companies, H1 2015 (Contd..16)
Products under Development by Companies, H1 2015 (Contd..17)
Products under Development by Companies, H1 2015 (Contd..18)
Products under Development by Companies, H1 2015 (Contd..19)
Products under Development by Companies, H1 2015 (Contd..20)
Products under Development by Companies, H1 2015 (Contd..21)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Colorectal Cancer – Pipeline by 2cureX ApS, H1 2015
Colorectal Cancer – Pipeline by 3-V Biosciences, Inc., H1 2015
Colorectal Cancer – Pipeline by 4SC AG, H1 2015
Colorectal Cancer – Pipeline by AB Science, H1 2015
Colorectal Cancer – Pipeline by AbbVie Inc., H1 2015
Colorectal Cancer – Pipeline by Actinium Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Adamed Sp. z o.o., H1 2015
Colorectal Cancer – Pipeline by Advaxis, Inc., H1 2015
Colorectal Cancer – Pipeline by Advenchen Laboratories, LLC, H1 2015
Colorectal Cancer – Pipeline by Aeterna Zentaris Inc., H1 2015
Colorectal Cancer – Pipeline by Alchemia Limited, H1 2015
Colorectal Cancer – Pipeline by Allinky Biopharma, H1 2015
Colorectal Cancer – Pipeline by Amgen Inc., H1 2015
Colorectal Cancer – Pipeline by Angiogene Pharmaceuticals Limited, H1 2015
Colorectal Cancer – Pipeline by Antibe Therapeutics, Inc., H1 2015
Colorectal Cancer – Pipeline by Aphios Corporation, H1 2015
Colorectal Cancer – Pipeline by Arisaph Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by ArQule, Inc., H1 2015
Colorectal Cancer – Pipeline by Array BioPharma Inc., H1 2015
Colorectal Cancer – Pipeline by Astellas Pharma Inc., H1 2015
Colorectal Cancer – Pipeline by Astex Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by AstraZeneca Plc, H1 2015
Colorectal Cancer – Pipeline by AVEO Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Basilea Pharmaceutica AG, H1 2015
Colorectal Cancer – Pipeline by Bavarian Nordic A/S, H1 2015
Colorectal Cancer – Pipeline by Bayer AG, H1 2015
Colorectal Cancer – Pipeline by Biocon Limited, H1 2015
Colorectal Cancer – Pipeline by Bionomics Limited, H1 2015
Colorectal Cancer – Pipeline by BioNovion B.V., H1 2015
Colorectal Cancer – Pipeline by Biothera, Inc., H1 2015
Colorectal Cancer – Pipeline by Boehringer Ingelheim GmbH, H1 2015
Colorectal Cancer – Pipeline by Boston Biomedical, Inc., H1 2015
Colorectal Cancer – Pipeline by Bristol-Myers Squibb Company, H1 2015
Colorectal Cancer – Pipeline by Burzynski Research Institute, Inc., H1 2015
Colorectal Cancer – Pipeline by cCAM Biotherapeutics Ltd., H1 2015
Colorectal Cancer – Pipeline by CCRP Therapeutics GmbH, H1 2015
Colorectal Cancer – Pipeline by Celator Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Celgene Corporation, H1 2015
Colorectal Cancer – Pipeline by Celldex Therapeutics, Inc., H1 2015
Colorectal Cancer – Pipeline by Cellectar Biosciences, Inc., H1 2015
Colorectal Cancer – Pipeline by Cellectis S.A., H1 2015
Colorectal Cancer – Pipeline by Celltrion, Inc., H1 2015
Colorectal Cancer – Pipeline by Cellular Biomedicine Group, Inc., H1 2015
Colorectal Cancer – Pipeline by Celon Pharma Sp. z o.o., H1 2015
Colorectal Cancer – Pipeline by Celsion Corporation, H1 2015
Colorectal Cancer – Pipeline by Chipscreen Biosciences Ltd, H1 2015
Colorectal Cancer – Pipeline by Chugai Pharmaceutical Co., Ltd., H1 2015
Colorectal Cancer – Pipeline by Cornerstone Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Critical Outcome Technologies Inc., H1 2015
Colorectal Cancer – Pipeline by CritiTech, Inc., H1 2015
Colorectal Cancer – Pipeline by CrystalGenomics, Inc., H1 2015
Colorectal Cancer – Pipeline by CTI BioPharma Corp., H1 2015
Colorectal Cancer – Pipeline by CureTech Ltd., H1 2015
Colorectal Cancer – Pipeline by Cytune Pharma SAS, H1 2015
Colorectal Cancer – Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Colorectal Cancer – Pipeline by DanDrit Biotech A/S, H1 2015
Colorectal Cancer – Pipeline by Deciphera Pharmaceuticals, LLC, H1 2015
Colorectal Cancer – Pipeline by Dicerna Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Digna Biotech, S.L., H1 2015
Colorectal Cancer – Pipeline by Eddingpharm, H1 2015
Colorectal Cancer – Pipeline by Eisai Co., Ltd., H1 2015
Colorectal Cancer – Pipeline by Eli Lilly and Company, H1 2015
Colorectal Cancer – Pipeline by EntreChem, S.L., H1 2015
Colorectal Cancer – Pipeline by Enzo Biochem, Inc., H1 2015
Colorectal Cancer – Pipeline by Epirus Biopharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Etubics Corporation, H1 2015
Colorectal Cancer – Pipeline by Exelixis, Inc., H1 2015
Colorectal Cancer – Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Colorectal Cancer – Pipeline by Fusion Antibodies Limited, H1 2015
Colorectal Cancer – Pipeline by Genentech, Inc., H1 2015
Colorectal Cancer – Pipeline by Genor BioPharma Co., Ltd., H1 2015
Colorectal Cancer – Pipeline by Gilead Sciences, Inc., H1 2015
Colorectal Cancer – Pipeline by GlaxoSmithKline Plc, H1 2015
Colorectal Cancer – Pipeline by Glycotope GmbH, H1 2015
Colorectal Cancer – Pipeline by Golden Biotechnology Corp., H1 2015
Colorectal Cancer – Pipeline by Gradalis Inc., H1 2015
Colorectal Cancer – Pipeline by Green Cross Corporation, H1 2015
Colorectal Cancer – Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015
Colorectal Cancer – Pipeline by Helix BioPharma Corp., H1 2015
Colorectal Cancer – Pipeline by Hemispherx Biopharma, Inc., H1 2015
Colorectal Cancer – Pipeline by Hospira, Inc., H1 2015
Colorectal Cancer – Pipeline by Hutchison MediPharma Limited, H1 2015
Colorectal Cancer – Pipeline by iDD biotech SAS, H1 2015
Colorectal Cancer – Pipeline by Ignyta, Inc., H1 2015
Colorectal Cancer – Pipeline by immatics biotechnologies GmbH, H1 2015
Colorectal Cancer – Pipeline by Immodulon Therapeutics Ltd., H1 2015
Colorectal Cancer – Pipeline by ImmuneXcite, Inc., H1 2015
Colorectal Cancer – Pipeline by ImmunNovative Developments SL, H1 2015
Colorectal Cancer – Pipeline by Immunomedics, Inc., H1 2015
Colorectal Cancer – Pipeline by Immunovative Therapies, Ltd., H1 2015
Colorectal Cancer – Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015
Colorectal Cancer – Pipeline by Incuron, LLC, H1 2015
Colorectal Cancer – Pipeline by Incyte Corporation, H1 2015
Colorectal Cancer – Pipeline by Innovent Biologics, Inc., H1 2015
Colorectal Cancer – Pipeline by Interprotein Corporation, H1 2015
Colorectal Cancer – Pipeline by Isis Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Isofol Medical AB, H1 2015
Colorectal Cancer – Pipeline by ISU ABXIS Co.,Ltd., H1 2015
Colorectal Cancer – Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H1 2015
Colorectal Cancer – Pipeline by Kadmon Corporation, LLC, H1 2015
Colorectal Cancer – Pipeline by Kancera AB, H1 2015
Colorectal Cancer – Pipeline by Karyopharm Therapeutics, Inc., H1 2015
Colorectal Cancer – Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2015
Colorectal Cancer – Pipeline by Laboratorio Elea S.A.C.I.F. and A, H1 2015
Colorectal Cancer – Pipeline by Lee's Pharmaceutical Holdings Limited, H1 2015
Colorectal Cancer – Pipeline by LivTech, Inc., H1 2015
Colorectal Cancer – Pipeline by Lymphocyte Activation Technologies, S.A., H1 2015
Colorectal Cancer – Pipeline by Mabion SA, H1 2015
Colorectal Cancer – Pipeline by MacroGenics, Inc., H1 2015
Colorectal Cancer – Pipeline by MedImmune, LLC, H1 2015
Colorectal Cancer – Pipeline by Merck & Co., Inc., H1 2015
Colorectal Cancer – Pipeline by Merck KGaA, H1 2015
Colorectal Cancer – Pipeline by Merrimack Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Millennium Pharmaceuticals, Inc., H1 2015
Colorectal Cancer – Pipeline by Mirna Therapeutics, Inc., H1 2015
Colorectal Cancer – Pipeline by MolMed S.p.A., H1 2015
Colorectal Cancer – Pipeline by Mologen AG, H1 2015
Colorectal Cancer – Pipeline by Morphotek, Inc., H1 2015
Colorectal Cancer – Pipeline by Multimmune GmbH, H1 2015
Colorectal Cancer – Pipeline by Natco Pharma Limited, H1 2015
Colorectal Cancer – Pipeline by NatureWise Biotech & Medicals Corporation, H1 2015
Colorectal Cancer – Pipeline by Nektar Therapeutics, H1 2015
Colorectal Cancer – Pipeline by Nerviano Medical Sciences S.r.l., H1 2015
Colorectal Cancer – Pipeline by Nippon Kayaku Co., Ltd., H1 2015
Colorectal Cancer – Pipeline by Northwest Biotherapeutics, Inc., H1 2015

List of Figures
Number of Products under Development for Colorectal Cancer, H1 2015
Number of Products under Development for Colorectal Cancer – Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

2cureX ApS
3-V Biosciences, Inc.
4SC AG
AB Science
AbbVie Inc.
Actinium Pharmaceuticals, Inc.
Adamed Sp. z o.o.
Advaxis, Inc.
Advenchen Laboratories, LLC
Aeterna Zentaris Inc.
Alchemia Limited
Allinky Biopharma
Amgen Inc.
Angiogene Pharmaceuticals Limited
Antibe Therapeutics, Inc.
Aphios Corporation
Arisaph Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Astellas Pharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Basilea Pharmaceutica AG
Bavarian Nordic A/S
Bayer AG
Beta Cat Pharmaceuticals, LLC
Biocon Limited
Bionomics Limited
BioNovion B.V.
Biothera, Inc.
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Burzynski Research Institute, Inc.
cCAM Biotherapeutics Ltd.
CCRP Therapeutics GmbH
Celator Pharmaceuticals, Inc.
Celgene Corporation
Celldex Therapeutics, Inc.
Cellectar Biosciences, Inc.
Cellectis S.A.
Celltrion, Inc.
Cellular Biomedicine Group, Inc.
Celon Pharma Sp. z o.o.
Celsion Corporation
Chipscreen Biosciences Ltd
Chugai Pharmaceutical Co., Ltd.
Cornerstone Pharmaceuticals, Inc.
Critical Outcome Technologies Inc.
CritiTech, Inc.
CrystalGenomics, Inc.
CTI BioPharma Corp.
CureTech Ltd.
Cytune Pharma SAS
Daiichi Sankyo Company, Limited
DanDrit Biotech A/S
Deciphera Pharmaceuticals, LLC
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Eddingpharm
Eisai Co., Ltd.
Eli Lilly and Company
EntreChem, S.L.
Enzo Biochem, Inc.
Epirus Biopharmaceuticals, Inc.
Etubics Corporation
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Fusion Antibodies Limited
Genentech, Inc.
Genor BioPharma Co., Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Glycotope GmbH
Golden Biotechnology Corp.
Gradalis Inc.
Green Cross Corporation
Hanmi Pharmaceuticals, Co. Ltd.
Helix BioPharma Corp.
Hemispherx Biopharma, Inc.
Hospira, Inc.
Hutchison MediPharma Limited
iDD biotech SAS
Ignyta, Inc.
immatics biotechnologies GmbH
Immodulon Therapeutics Ltd.
ImmuneXcite, Inc.
ImmunNovative Developments SL
Immunomedics, Inc.
Immunovative Therapies, Ltd.
Inbiopro Solutions Pvt. Ltd.
Incuron, LLC
Incyte Corporation
Innovent Biologics, Inc.
Interprotein Corporation
Isis Pharmaceuticals, Inc.
Isofol Medical AB
ISU ABXIS Co.,Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
Kadmon Corporation, LLC
Kancera AB
Karyopharm Therapeutics, Inc.
Kyowa Hakko Kirin Co., Ltd.
Laboratorio Elea S.A.C.I.F. and A
Lee's Pharmaceutical Holdings Limited
LivTech, Inc.
Lymphocyte Activation Technologies, S.A.
Mabion SA
MacroGenics, Inc.
MedImmune, LLC
Merck & Co., Inc.
Merck KGaA
Merrimack Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
MolMed S.p.A.
Mologen AG
Morphotek, Inc.
Multimmune GmbH
Natco Pharma Limited
NatureWise Biotech & Medicals Corporation
Nektar Therapeutics
Nerviano Medical Sciences S.r.l.
Nippon Kayaku Co., Ltd.
Northwest Biotherapeutics, Inc.
Novartis AG
NuCana BioMed Limited
Oncobiologics, Inc.
Oncology Research International Limited
Oncolytics Biotech Inc.
Onconova Therapeutics, Inc.
Oncothyreon Inc.
Otsuka Holdings Co., Ltd.
Oxford BioMedica Plc
Panacea Biotec Limited
Pfizer Inc.
Pharma Mar, S.A.
Pharmacyclics, Inc.
Philogen S.p.A.
Pivotal BioSciences, Inc.
Plexxikon Inc.
PLx Pharma Inc.
Precision Biologics, Inc.
PsiOxus Therapeutics Limited
Puma Biotechnology, Inc.
Quimatryx, S.L.
Redx Pharma Plc
Regeneron Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc.
Sanofi
Selvita SA
Serina Therapeutics, Inc.
Shanghai Henlius Biotech Co., Ltd.
Sigmoid Pharma Limited
Simcere Pharmaceutical Group
Solvotrin Therapeutics Limited
Sumitomo Dainippon Pharma Co., Ltd.
Sunesis Pharmaceuticals, Inc.
Symphogen A/S
Syndax Pharmaceuticals, Inc.
Tactic Pharma, LLC
Taiho Pharmaceutical Co., Ltd.
Targovax AS
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries Limited
Theravectys S.A.
TheRyte Limited
TRACON Pharmaceuticals, Inc.
Transgene SA
Vaccinex, Inc.
VasGene Therapeutics, Inc.
Vaxeal Holding SA
Viralytics Ltd.
Wilex AG
WntResearch AB
XBiotech USA, Inc.
Zymeworks Inc.
Zyngenia, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Cache

Our Clients

  • Celgene Corporation
  • Eli Lilly and Company
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Bristol-Myers Squibb